Navigation Links
Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
Date:12/28/2009

acute radiation enteritis. Additionally, Soligenix has a Lipid Polymer Micelle (LPM(TM)) drug delivery technology for the oral delivery of leuprolide for the treatment of prostate cancer and endometriosis.

Through its Biodefense Division, Soligenix is developing biomedical countermeasures pursuant to the Project BioShield Act of 2004. Soligenix's lead biodefense product in development is a recombinant subunit vaccine called RiVax(TM), which is designed to protect against the lethal effects of exposure to ricin toxin. RiVax(TM) has been shown to be well tolerated and immunogenic in a Phase 1 clinical trial in normal volunteers. RiVax((TM)) will also be the subject of a recent $9.4 million NIH grant received by the Company supporting development of new heat stable vaccines.

For further information regarding Soligenix, Inc., please visit the Company's website at www.soligenix.com.

This press release contains forward-looking statements that reflect Soligenix, Inc.'s current expectations about its future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes," "intends," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. Soligenix cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including SGX201, orBec(®) and LPM((TM)), particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting prec
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Soligenix Announces Initiation of a Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis
2. Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... YORK , Feb. 27, 2015  Pomerantz LLP ... Pharmaceuticals, Inc. ("Vitae" or the "Company") (NASDAQ: ... Robert S. Willoughby at rswilloughby@pomlaw.com or ... Vitae and certain of its officers and/or directors have ... Act of 1934.  On February 27, ...
(Date:2/27/2015)... 2015 Securities lawyers at Dunnam & ... Ltd. (NASDAQ: SLXP ) in connection with ... investors are encouraged to contact attorney Hamilton Lindley by ... focuses upon the shareholder value of the transaction. Under ... only $158.00 per share in cash. At least one ...
(Date:2/27/2015)... Report Details   ... R&D progress, and predicted revenues ,Where is the market ... commercial prospects for this market and related technologies? Visiongain,s ... trends to 2025, discussing data, opportunities and prospects. ... regenerative medicine : cell-based therapies that aim to restore ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vitae Pharmaceuticals, Inc. - VTAE 2Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8
... VIEW, Calif., Feb. 23, 2011 Omnicell, Inc ... of medication management systems to healthcare facilities, today announced ... 100 healthcare executives were polled to identify trends in ... purchasing decisions. The survey found that the majority of ...
... Biomatrica, Inc., a leader in room temperature biostability ... In-Q-Tel (IQT). IQT is the independent, strategic investment ... the mission of the U.S. Intelligence Community. ... has pioneered recent innovations in ambient storage of ...
Cached Medicine Technology:75 Percent of Hospital IT Leaders View Interoperability Between Vendor Systems as Critical to Operational Effectiveness in Healthcare Settings 2Biomatrica Secures Strategic Investment from IQT 2Biomatrica Secures Strategic Investment from IQT 3
(Date:3/2/2015)... March 02, 2015 Secura Consultants ... relationship with First Protective Insurance Group of Birmingham, ... allow First Protective affiliated advisors to access the ... that Secura Consultants delivers. , Secura ... leader in the design and implementation of insured ...
(Date:3/1/2015)... March 01, 2015 Women’s Excellence is ... Obstetric terms on their website. There are over 75 ... the time. , “This gives our patients a better ... medical terminology that they may not understand. With this resource, ... is mobile optimized) and find terms and phrases that they may ...
(Date:3/1/2015)... NC (PRWEB) March 01, 2015 Researchers ... reason that so many sheet metal workers contract malignant ... this new report on its website. Click here ... Center for Construction Research and Training monitored 17,345 sheet ... a disproportionate number of them died of mesothelioma ...
(Date:3/1/2015)... 01, 2015 Indiana Fiber Network, ... Provider, announces NewWays Networking, LLC (NewWays) selected IFN ... with IFN, NewWays is well positioned to scale ... for Internet bandwidth in rural parts of Indiana,” ... to Cory Childs IFN Enterprise Sales Manager, IFN ...
(Date:3/1/2015)... Vancouver, WA (PRWEB) February 28, 2015 CrossFit ... This spring they are offering a special discount to new ... who sign up for a three month contract will receive ... each month individually would cost members $440. The three ... $88 per month, and then the fourth month comes in ...
Breaking Medicine News(10 mins):Health News:Secura Consultants and First Protective Insurance Group Announce Strategic Relationship 2Health News:New Study Finds Indirect Asbestos Exposure Can Raise Mesothelioma Risk for Sheet Metal Workers, According to Surviving Mesothelioma 2Health News:NewWays Networking Selects Indiana Fiber Network, LLC as Fiber Transport Provider 2Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2
... was no better than placebo, study finds , , MONDAY, ... (Trileptal) does not seem to prevent migraines, as once ... than 28 million Americans, and certain epilepsy drugs have ... headaches. For this reason, many assumed that oxcarbazepine would ...
... at Annual Meeting of the American Academy of ... ... NeoStrata today released new,clinical data that demonstrates significant benefits in combining,microdermabrasion ... products in improving the appearance,and texture of facial skin. The data ...
... for donations is spiraling for older couples wanting to start ... ... Radical shifts in parenting,trends have fertility experts at Reproductive Endocrinology Associates of,Charlotte ... in 2008 -- including new outreach through the Internet --,in efforts to ...
... the day that we,celebrate love approaches, many people with memory-impaired ... sustain a loving,relationship with someone who no longer knows who ... a new understanding of love itself., "It,s important to ... matters most is doing things that make him or her ...
... Show All 89 Inspected Pennsylvania Facilities Meet Federal,Standards, ... of,Environmental Protection reported today that all of the ... are operating within,the guidelines set forth by the ... each of Pennsylvania,s approximately 400 certified,mammography facilities annually ...
... saturate TV, radio, and print with anti-Meth ... ... The Illinois Meth Project,today launched a campaign to prevent first-time methamphetamine ... a research-based prevention program that educates people,about the dangers of Meth ...
Cached Medicine News:Health News:Epilepsy Drug Doesn't Prevent Migraines 2Health News:NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin 2Health News:Charlotte IVF Experts Issue Urgent Call for Egg Donors, Eye New Recruiting Tools 2Health News:Loving the Memory-Impaired: A New Perspective on Valentine's Day 2Health News:Pennsylvania DEP Releases 4th Quarter 2007 Mammography Inspection Results 2Health News:Pennsylvania DEP Releases 4th Quarter 2007 Mammography Inspection Results 3Health News:Pennsylvania DEP Releases 4th Quarter 2007 Mammography Inspection Results 4Health News:Illinois Meth Project Launches Large-Scale Meth Prevention Campaign 2Health News:Illinois Meth Project Launches Large-Scale Meth Prevention Campaign 3Health News:Illinois Meth Project Launches Large-Scale Meth Prevention Campaign 4
... of the series. It has the ability to photograph ... cornea. The model comes with a 9 high-resolution black ... patients corneal endothelium, you simply ask the patient to ... The left side of the chin rest allows you ...
The simplest, most accurate Ortho-K lens fitting system ever!...
... The Euclid Systems Orthokeratology (oprifocon A) ... contact lenses used for orthokeratology, a ... The patient wears these lenses overnight ... During the day, nearsightedness is temporarily ...
... These are rigid gas permeable contact ... process that temporarily corrects nearsightedness (myopia). The ... and removes them upon wakening. During the ... ,The Paragon CRT and Quadra RG contact ...
Medicine Products: